Oscar Health, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 270.73 million compared to USD 606.28 million a year ago. Basic loss per share from continuing operations was USD 1.22 compared to USD 2.85 a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
21.62 USD | -2.50% | +19.67% | +135.68% |
05-09 | Goldman Sachs Adjusts Price Target on Oscar Health to $21 From $16, Maintains Neutral Rating | MT |
05-07 | Sector Update: Health Care Stocks Advance in Late Afternoon Trading | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+135.68% | 5.25B | |
+26.90% | 10.79B | |
+2.53% | 6.62B | |
+19.97% | 6.25B | |
+0.95% | 2.39B | |
-15.99% | 1.05B | |
+135.42% | 949M | |
-0.42% | 849M | |
+6.42% | 160M | |
-6.17% | 71.09M |
- Stock Market
- Equities
- OSCR Stock
- News Oscar Health, Inc.
- Oscar Health, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023